期刊文献+

血清AFP倍增时间、肿瘤体积倍增时间与肝癌分化程度的相关性分析 被引量:6

下载PDF
导出
摘要 目的评价血清APF倍增时间(T2AFP),肿瘤体积倍增时间(TVDT)与肝癌分化程度的关系。方法应用螺旋CT扫描测量肿瘤直径,电化学发光法检测AFP血清水平。比较肿瘤体积倍增时间与肝癌分化程度之间的相关性;肝癌患者血清AFP>100 ng/ml,比较AFP倍增时间与分化程度之间的关系;分析APF倍增时间和肿瘤体积倍增时间之间的相关性。结果按Edmondson grade分级Ed2、Ed3和Ed4肿瘤体积倍增时间分别为:(159.2±140.3)、(86.7±67.3)和(54.2±31.9)d(P<0.05);Ed2、Ed3和Ed4的AFP倍增时间分别为:(193.6±174.2)、(141.0±124.5)和(57.3±44.6)d(P<0.05)。T2AFP和TDVT间呈正相关性(r=0.76,P<0.05);TVDT和T2AFP在低分化肝癌中明显缩短。结论 TVDT和T2AFP可以作为肝癌分化程度及预后评价的指标。
出处 《河北医药》 CAS 2016年第1期112-114,共3页 Hebei Medical Journal
  • 相关文献

参考文献11

  • 1Fukuda S, hamoto T, Nakahara H, et al. Clinicopathol0gic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. H epatogastroenterology, 2005,52 : 1163 -1167.
  • 2Oishi K, hamoto T, Amano H, et al. Clinicopathologic features of poorly differentiated hepatocellular carcinoma. J Surg Oncol, 2007,95 : 311-316.
  • 3Johnson PJ, Williams R. Serum alpha-fetoprotein estimations and doubling time in hepatoccllular carcinoma : influence of therapy and possible value in early detection. J Natl Cancer Inst,1980 ,64 :1329-1332.
  • 4Shingaki N, Tamai H, Mori Y, et al. Serological and histological indices ofhepatocellular carcinoma and tumor volume doubling time. Mol Clin Onco1,2013 ,1:977-981.
  • 5Miyaaki H, Nakashima O, Kurogi M, et al. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis : a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol, 2007,42 : 962- 968.
  • 6Bolondi L, Benzi G, Santi V, et al. Relationship between alpha-fetoprotein serum levels,tumour volume and growth rate of hepatocellular carcinoma in a western population. Ital J Gastroenterol, 1990,22 : 190-194.
  • 7Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis : a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology, 1992,16: 132-137.
  • 8Kabota K, Ina H, Okada Y, et al. Growth rate of primary single hepatocellular carcinoma:determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci,2003,48:581-586.
  • 9Taouli B, Goh JS, Lu Y, et al. Growth rate of hepatocellular carcinoma : evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr, 2005,29:425 -429.
  • 10Furlan A, Marin D, Agnello F,et al. Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small ( ≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. J Comput Assist Tomogr,2012 ,36 :20-25.

同被引文献69

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部